Proto-oncogene tyrosine-protein kinase Src
Details
- Name
- Proto-oncogene tyrosine-protein kinase Src
- Kind
- protein
- Organism
- Humans
- Protein
Name UniProt ID Proto-oncogene tyrosine-protein kinase Src P12931 Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB01254 Dasatinib approved, investigational yes inhibitormultitarget Details DB01893 N6-Benzyl Adenosine-5'-Diphosphate experimental unknown Details DB01908 RU85493 experimental unknown Details DB01962 Phosphonotyrosine experimental unknown Details DB02175 Malonic acid experimental unknown Details DB02336 RU83876 experimental unknown Details DB02432 RU90395 experimental unknown Details DB02908 RU78783 experimental unknown Details DB03104 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid experimental unknown Details DB03268 RU82197 experimental unknown Details DB03298 Phenylphosphate experimental unknown Details DB03591 RU82209 experimental unknown Details DB03712 RU85053 experimental unknown Details DB03902 Oxalic Acid experimental unknown Details DB04272 Citric acid approved, nutraceutical, vet_approved unknown Details DB04495 Paratoulene phosphate experimental unknown Details DB01678 RU84687 experimental unknown Details DB04739 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE experimental unknown Details DB04751 Purvalanol A experimental unknown Details DB05184 XL228 investigational unknown Details DB06137 Tirbanibulin approved, investigational yes inhibitor Details DB06882 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea experimental unknown Details DB06883 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea experimental unknown Details DB03114 PAS219 experimental unknown Details DB01866 RU79256 experimental unknown Details DB01947 RU78262 experimental unknown Details DB03828 RU78299 experimental unknown Details DB03306 RU78300 experimental unknown Details DB02762 RU79072 experimental unknown Details DB03525 RU79073 experimental unknown Details DB04080 RU78191 experimental unknown Details DB07335 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL experimental unknown Details DB07662 PD-168393 experimental unknown Details DB03217 DPI59 experimental unknown Details DB07966 [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile experimental unknown Details DB03628 ISO24 experimental unknown Details DB08052 PP-121 experimental unknown Details DB08053 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine experimental unknown Details DB08054 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine experimental unknown Details DB08192 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE experimental unknown Details DB03023 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine experimental unknown Details DB03078 PASBN experimental unknown Details DB08462 N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE experimental unknown Details DB08564 (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide experimental unknown Details DB06616 Bosutinib approved yes inhibitor Details DB08901 Ponatinib approved, investigational unknown inhibitor Details DB09079 Nintedanib approved unknown inhibitor Details DB12010 Fostamatinib approved, investigational unknown inhibitor Details